A
ARMP
Armata Pharmctcl
7.78
+0.21+2.77%After Hours: 7.78 0.00 0.00%16:10 06/09 EDT
OPEN/PREV CLOSE7.66/7.57
TODAY RANGE6.71-8.00
VOL123.81K
MARKET CAP285.61M
52 WEEK RANGE1.740-16.34
AVG VOL (3M)60.98K
% TURNOVER0.34%
TURNOVER--
P/E (TTM)-1.0022
% RANGE17.01%
EPS(TTM)-7.7633
P/E(FORWARD)-2.0447
P/B-0.9150
BVPS-8.5029
DIVIDEND--
P/S57.80
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP89.89M
SHARES OUTSTANDING36.71M
NEXT EARNINGS08/10-08/14
FREE FLOAT11.55M
LOT SIZE1
EX-DATE05/10/2019
News
Press Releases
Financial Reports
Profile
TipRanks·05/14 10:44
H.C. Wainwright Reaffirms Their Buy Rating on Armata Pharmaceuticals (ARMP)
TipRanks·05/13 22:17
Armata Secures New Loan Amid Wider Quarterly Loss
TipRanks·05/13 21:41
Armata Pharmaceuticals reports Q1 EPS ($3.16) vs. (20c) last year
Seeking Alpha·05/13 20:53
Armata Pharmaceuticals GAAP EPS of -$3.16 misses by $2.78, revenue of $0.79M
Dow Jones·05/13 20:41
*Armata Pharmaceuticals 1Q Loss $115.3M >ARMP
Dow Jones·05/13 20:30
Press Release: Armata Pharmaceuticals Announces -3-
PR Newswire·05/13 20:30
Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update
Dow Jones·05/13 20:30
*Armata Pharmaceuticals 1Q Loss/Shr $3.16 >ARMP
TipRanks·05/07 13:17
Armata Pharmaceuticals secures FDA Fast Track Designation for AP-SA02
TipRanks·05/07 11:57
Armata Gains FDA Fast Track for AP-SA02 Therapy
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.